Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secukinumab”

202 trials

Showing 20 of 202 results

Not applicableLooking for participantsNCT07109765
What this trial is testing

Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa (HS)
Peking Union Medical College 50
Large-scale testing (Phase 3)Study completedNCT01358175
What this trial is testing

16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Novartis Pharmaceuticals 371
Large-scale testing (Phase 3)Ended earlyNCT01770379
What this trial is testing

Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 242
Large-scale testing (Phase 3)Study completedNCT03769168
What this trial is testing

An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)

Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis Related Arthritis
Novartis Pharmaceuticals 55
Large-scale testing (Phase 3)Study completedNCT02471144
What this trial is testing

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Who this might be right for
Chronic Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 162
Not applicableAvailableNCT05583604
What this trial is testing

Managed Access Programs for AIN457, Secukinumab

Who this might be right for
Hidradenitis Suppurativa (HS)
Novartis Pharmaceuticals
Not applicableStudy completedNCT05513014
What this trial is testing

Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With Psoriasis

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 1,518
Large-scale testing (Phase 3)Study completedNCT04209205
What this trial is testing

Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 381
Large-scale testing (Phase 3)Study completedNCT02896127
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondyloarthritis
Novartis Pharmaceuticals 458
Post-approval studies (Phase 4)Active Not RecruitingNCT05622708
What this trial is testing

Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission

Who this might be right for
Non-radiographic Axial Spondyloarthritis
Novartis Pharmaceuticals 240
Large-scale testing (Phase 3)Study completedNCT01555125
What this trial is testing

First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 177
Early research (Phase 1)Study completedNCT01539213
What this trial is testing

Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mg

Who this might be right for
HealthyPsoriasis
Novartis Pharmaceuticals 16
Not applicableEnded earlyNCT06715254
What this trial is testing

A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil

Who this might be right for
Tuberculosis
Novartis Pharmaceuticals 152
Early research (Phase 1)Study completedNCT06130540
What this trial is testing

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR

Who this might be right for
Giant Cell ArteritisPolymyalgia Rheumatica
Novartis Pharmaceuticals 65
Not applicableWithdrawnNCT06431750
What this trial is testing

Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)WithdrawnNCT03866317
What this trial is testing

Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus Erythematosus
Massachusetts General Hospital
Post-approval studies (Phase 4)Study completedNCT03020199
What this trial is testing

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 196
Not applicableActive Not RecruitingNCT06142357
What this trial is testing

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Novartis Pharmaceuticals 199
Large-scale testing (Phase 3)Study completedNCT04711902
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 41
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation